Related Experiment Video
Updated: Jun 19, 2026

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
Published on: August 20, 2019
Blau syndrome-related CARD15/NOD2 mutations are not linked to idiopathic uveitis in Spanish patients
Noelia Rodríguez-Pérez1, Ana Aguinaga-Barrilero, Marina B Gorroño-Echebarría
1Inmunología, Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Spain.
Insights
Blau syndrome is linked to CARD15 (NOD2) mutations, but these specific mutations were not found in Spanish patients with idiopathic uveitis. This suggests different genetic causes for Blau-associated uveitis and idiopathic uveitis.
Area of Science:
- Genetics
- Ophthalmology
- Immunology
Background:
- Uveitis is a key feature of Blau syndrome, a genetic disorder associated with CARD15 (NOD2) mutations.
- Specific CARD15 (NOD2) mutations (R334W, R334Q, L469F) are known risk factors for Blau syndrome.
- The role of these CARD15 (NOD2) mutations in idiopathic uveitis remains largely unexplored.
Purpose of the Study:
- To investigate the frequency of Blau syndrome-associated CARD15 (NOD2) mutations in a Spanish cohort of patients with idiopathic uveitis.
- To compare the prevalence of these mutations in idiopathic uveitis patients versus a healthy control group.
Main Methods:
- A cohort of 110 Spanish patients diagnosed with idiopathic uveitis was recruited.
- A control group of 104 healthy individuals was included for comparison.
- DNA analysis for specific CARD15 (NOD2) mutations (R334W, R334Q, L469F) was performed using PCR-RFLP or direct DNA sequencing.
Main Results:
- No instances of the studied CARD15 (NOD2) mutations were detected in any of the idiopathic uveitis patients.
- The specific Blau syndrome-related CARD15 (NOD2) mutations were also absent in the healthy control group.
- The frequency of these mutations in idiopathic uveitis was found to be zero.
Conclusions:
- The CARD15 (NOD2) mutations associated with Blau syndrome do not appear to be a contributing factor in the development of idiopathic uveitis within the studied Spanish population.
- This finding indicates that the genetic underpinnings of idiopathic uveitis likely differ from those of Blau syndrome-associated uveitis.
- Further research into the distinct genetic etiologies of these conditions is warranted.
Abstract:
Uveitis is a clinical feature of the Blau syndrome, a disease linked to CARD15 (also referred to as NOD2) mutations. Three main mutations in this gene (R334W, R334Q and L469F) have been reported as Blau syndrome risk factors, a disease that manifests uveitis as one of its clinical features. However, little is known on the involvement of this gene in idiopathic uveitis. We thus sought to determine the frequency of these Blau-related CARD15 mutations in a cohort of Spanish patients with idiopathic uveitis. To this aim, 110 patients with idiopathic uveitis, followed at the Department of Ophtalmology of a tertiary hospital (Hospital Universitario Alcalá de Henares, Madrid. Spain) were enrolled. As a control population, 104 healthy subjects were used. DNA was extracted from blood samples and the Blau-related CARD15 mutations were analysed either by PCR-RFLP or direct DNA sequencing. None of the mutations studied was found in any of the individuals tested, whether diseased or healthy. It seems thus that Blau syndrome-related CARD15 mutations are not involved in idiopathic uveitis, a finding which allows us to suggest that the genetic aetiology of the idiopathic uveitis or the Blau-associated uveitis is different.
More Related Videos
Related Concept Videos
Genetic Lingo
Pleiotropy
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Changes in Skin Color: Clinical Perspectives
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...

